(2-butyl-5-nitro-1-benzofuran-3-yl)-[4-[3-(dibutylamino)propoxy]phenyl]methanone

(2-butyl-5-nitro-1-benzofuran-3-yl)-[4-[3-(dibutylamino)propoxy]phenyl]methanone is used as the intermediate of Dronedarone .
Dronedarone is an antiarrhythmic drug. It is suitable for patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), reducing the risk of hospitalization, patients with recent AF / AFL attacks and cardiovascular risk factors, and patients with sinus rhythm or cardioversion. About the pharmacological action, pharmacokinetics, drug interaction, indications and adverse reactions of dronedarone